NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹20 Cr | ₹35 Cr | ₹14 Cr | ₹27 Cr | ₹20 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹20 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹27 Cr |
Mar2020 | ₹20 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹20 Cr | -42.00 | |
Mar2023 | ₹35 Cr | 155.23 | |
Mar2022 | ₹14 Cr | -49.46 | |
Mar2021 | ₹27 Cr | 33.67 | |
Mar2020 | ₹20 Cr | - |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,003.9 Cr | -1% | -10% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -1% |
-10% |
-12.7% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses